Nakashima M, Uchida T, Tsukazaki T, Hamanaka Y, Fukuda E, Ito M, Sekine I
Tissue and Histopathology Section, Division of Scientific Data Registry, Atomic Bomb Disease Institute, Nagasaki University School of Medicine, Japan.
Pathol Res Pract. 2001;197(2):101-7. doi: 10.1078/0344-0338-00017.
We have recently demonstrated that Tie-1 and Tie-2 are expressed in synovial cells from rheumatoid arthritis (RA). To elucidate the possible involvement of Tie receptors in synovial proliferation, we analyzed their expression by immunostaining in five cases of giant cell tumor of tendon sheath (GCTTS), which represents a proliferating lesion of synovial cells. Strong immunoreactivity for both Tie-1 and Tie-2, regardless of the individual patient's profile, was observed in all cases of GCTTS. Six sets of double immunohistochemical stainings for Tie-1/Tie-2 and fibronectin, CD68, or CD34 were carried out to determine the phenotype of Tie-1 and Tie-2-positive tumor components. In these studies, both Tie-1 and Tie-2 immunoreactivity were widely observed in the fibronectin-positive fibroblastic and the CD68-positive histiocytic mononuclear cells, as well as in the osteoclast-like giant cells. In tumor vasculature, Tie receptors were expressed in the CD34-positive endothelial cells possessing proliferating cell nuclear antigen (PCNA) immunoreactivity. We also evaluated the correlation of Tie-1/Tie-2 expression and proliferating cells in GCTTS by using double staining of Tie-1/Tie-2 together with PCNA. Overexpression of PCNA immunoreactivity was frequently found in Tie receptors-positive cells with no obvious differences in the expression pattern of Tie-1 and Tie-2. These findings suggest the possible involvement of Tie receptors in the pathogenesis of GCTTS other than solely via their involvement in angiogenesis and subsequent vascularization. It was demonstrated that Tie-2 immunoreactivity was restricted to the fibroblastic, but not histiocytic, phenotype in RA synovium, suggesting different regulatory control of Tie-2 expression in GCTTS and RA synovium. Overexpression of Tie receptors in GCTTS may imply a biological role for these receptors in synovial proliferation.
我们最近证实,Tie-1和Tie-2在类风湿关节炎(RA)的滑膜细胞中表达。为了阐明Tie受体可能参与滑膜增殖的情况,我们通过免疫染色分析了5例腱鞘巨细胞瘤(GCTTS)中它们的表达,GCTTS是一种滑膜细胞的增殖性病变。在所有GCTTS病例中,无论个体患者情况如何,均观察到Tie-1和Tie-2的强免疫反应性。进行了6组Tie-1/Tie-2与纤连蛋白、CD68或CD34的双重免疫组化染色,以确定Tie-1和Tie-2阳性肿瘤成分的表型。在这些研究中,Tie-1和Tie-2免疫反应性在纤连蛋白阳性的成纤维细胞、CD68阳性的组织细胞单核细胞以及破骨细胞样巨细胞中均广泛观察到。在肿瘤血管中,Tie受体在具有增殖细胞核抗原(PCNA)免疫反应性的CD34阳性内皮细胞中表达。我们还通过Tie-1/Tie-2与PCNA的双重染色评估了GCTTS中Tie-1/Tie-2表达与增殖细胞的相关性。PCNA免疫反应性的过表达在Tie受体阳性细胞中经常发现,Tie-1和Tie-2的表达模式无明显差异。这些发现表明,Tie受体可能参与GCTTS的发病机制,而不仅仅是通过其参与血管生成和随后的血管化。已证明,在RA滑膜中,Tie-2免疫反应性仅限于成纤维细胞表型,而非组织细胞表型,这表明GCTTS和RA滑膜中Tie-2表达的调控不同。GCTTS中Tie受体的过表达可能意味着这些受体在滑膜增殖中具有生物学作用。